The specialty pharmaceuticals market is forecasted to grow by USD 503.1 bn during 2024-2029, accelerating at a CAGR of 14.8% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, ...

CRISPR Gene Editing in Infectious Diseases: Market Overview Summary The report provides an overview of the potential of CRISPR-based therapeutics in the infectious disease space. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a precision gene-editing tool that enables targeted ...

The Anthrax Vaccine Market report by Precision Business Insights provides a comprehensive research approach combining primary and secondary research to ensure the highest possible accuracy in estimates and forecasts of the market size, share, growth, trends, key segments, competitive landscape, and ...

Kentley Insights’ 2025 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 202 ...

The HIV Diagnostics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for HIV Diagnostics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the i ...

Global Arbovirus Testing Market Trends and Outlook Arboviruses - arthropod-borne viruses transmitted by mosquitoes, ticks, and other blood-feeding insects - pose serious public health challenges worldwide. These viruses are responsible for diseases ranging from mild febrile illnesses to severe neuro ...

Antibody Market 2025-2029 The antibody market is forecasted to grow by USD 8958 mn during 2024-2029, accelerating at a CAGR of 8.3% during the forecast period. The report on the antibody market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as ...

Report Scope This report offers an analysis of the global market for infectious disease therapeutics, vaccines, and diagnostics. The infectious diseases covered in the report include human immunodeficiency virus (HIV) infection, seasonal influenza (including influenza A and B), hepatitis B, hepatiti ...

Global Hepatitis B Treatment Market to Reach US$5.4 Billion by 2030 The global market for Hepatitis B Treatment estimated at US$4.7 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Acute Type, one of the segments ana ...

UK Legionella Control - Industry Report The analysis conducted in the Legionella Control (UK) report is ideal for anyone wanting to • Identify the market leaders • Spot companies heading for failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their ...

The Precision Medicine Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to ...

This study covers the world outlook for point of care infectious diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for pneumonia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...

This study covers the world outlook for pneumonia testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the reg ...

This study covers the world outlook for pneumonia vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the re ...

This study covers the world outlook for pneumonia therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for pandemic infectious disease products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ...

This study covers the world outlook for antibacterial hospital acquired pneumonia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent s ...

This study covers the world outlook for infectious disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ...

This study covers the world outlook for infectious disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for healthcare acquired infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for DNA probes-based diagnostics for infectious diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perc ...

This study covers the world outlook for gram-positive bacterial infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the coun ...

This study covers the world outlook for communicable diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the regio ...